Y. Beyazit Et Al. , "Second-generation BCR-ABL kinase inhibitors in CML [3]," New England Journal of Medicine , vol.363, no.17, pp.1673, 2010
Beyazit, Y. Et Al. 2010. Second-generation BCR-ABL kinase inhibitors in CML [3]. New England Journal of Medicine , vol.363, no.17 , 1673.
Beyazit, Y., KEKILLI, M., & HAZNEDAROĞLU, İ. C., (2010). Second-generation BCR-ABL kinase inhibitors in CML [3]. New England Journal of Medicine , vol.363, no.17, 1673.
Beyazit, YAVUZ, Murat KEKILLI, And İBRAHİM CELALETTİN HAZNEDAROĞLU. "Second-generation BCR-ABL kinase inhibitors in CML [3]," New England Journal of Medicine , vol.363, no.17, 1673, 2010
Beyazit, YAVUZ Et Al. "Second-generation BCR-ABL kinase inhibitors in CML [3]." New England Journal of Medicine , vol.363, no.17, pp.1673, 2010
Beyazit, Y. KEKILLI, M. And HAZNEDAROĞLU, İ. C. (2010) . "Second-generation BCR-ABL kinase inhibitors in CML [3]." New England Journal of Medicine , vol.363, no.17, p.1673.
@article{article, author={YAVUZ BEYAZIT Et Al. }, title={Second-generation BCR-ABL kinase inhibitors in CML [3]}, journal={New England Journal of Medicine}, year=2010, pages={1673} }